Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
Key Details
- 1Heartflow is an imaging AI vendor specializing in noninvasive CT-based cardiac tests.
- 2The company raised $364 million from its IPO, up from the original $100 million target.
- 3Shares were sold at $19 each, with over 19 million shares issued.
- 4Heartflow uses CT data to generate personalized 3D models of coronary arteries.
- 5The company reported $126 million in revenue last year, growing 44% year-over-year.
- 6Estimated market opportunity for Heartflow's products exceeds $5 billion.
Why It Matters
This large capital raise highlights both investor confidence and strong demand for AI-powered cardiac imaging solutions. The funding will help Heartflow expand its reach among radiologists and further develop its imaging AI technology.
Source
Radiology Business
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•AuntMinnie
AI Mammography Tool Shows No Significant Benefit in Single-Reader U.S. Study
A real-world study found no significant improvement in breast cancer detection or recall rates with an FDA-approved AI mammography tool in a single-reader setting.